The Leadership Team at Mablink Bioscience is responsible for setting the strategic direction and vision of the company. They oversee the development and commercialization of innovative Antibody Drug Conjugates (ADCs) for cancer treatment, ensuring that financial, operational, and scientific objectives are met. This team collaborates to drive growth, maintain high-quality standards, and advance clinical development while fostering partnerships to enhance Mablink's impact in the biotechnology landscape.
Benoit Joseph
Co-Founder
David Doreau
Chief Quality Officer
Edouard LEROY
Chief Business Officer
Fréderique Brune
Chief Development Officer (CDO...
Jean-Guillaume Lafay
Chief Executive Officer & Co-F...
Pejvack Motlagh
Chief Medical Officer
Stanislas Sordet
Chief Financial Officer
Valérie Attuil
COO
Warren Viricel
Co-founder & Chief Scientific ...
View all